ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Second-Line Therapy Options in Metastatic Renal Cell Carcinoma

Second-Line Therapy Options in Metastatic Renal Cell Carcinoma

 

In this video, Neeraj Agarwal, MD, of the University of Utah Huntsman Cancer Institute, reviews the various treatment options for metastatic renal cell carcinoma in the second-line setting, including considerations of the different toxicity profiles.

Agarwal spoke on this topic at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.

By clicking Accept, you agree to become a member of the UBM Medica Community.